September 26, 2016 12:21 PM ET


Company Overview of The Translational Genomics Research Institute

Company Overview

The Translational Genomics Research Institute develops earlier diagnostics and treatments. It develops diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company also provides bio4d to offer tools for managing various aspects of the biospecimen lifecycle, including related data enabling clinical genomics data warehouse capabilities for data mining and integrative analysis for the discovery or validation of biomarkers, diagnostics, and therapeutics. In addition, The Translational Genomics Research Institute offers genome technology and core services; genome technology for performing contemporary genetic analysis to benefit the...

445 North Fifth Street

Phoenix, AZ 85004

United States

Founded in 2002





Key Executives for The Translational Genomics Research Institute

Founder, President, Research Director and Director
Vice President of Finance
Chief Operating Officer and President of TGen Health Ventures
President of TGen Foundation
Executive Vice President and Physician-In-Chief
Age: 68
Compensation as of Fiscal Year 2016.

The Translational Genomics Research Institute Key Developments

Spectrum Health Collaborates with Dell and Translational Genomics Research Institute to Expand International Pediatric Cancer Research to Lebanon

Spectrum Health announced its engagement in international pediatric cancer research. Together with Helen DeVos Children's Hospital, Dell and the Translational Genomics Research Institute, Spectrum Health will bring a personalized medicine clinical trial to children fighting pediatric cancers in Lebanon. Led by Giselle Sholler, MD, MSC, director of pediatric oncology research, Helen DeVos Children's Hospital and Jeffery Trent, PhD, FACMG, president and research director, TGen, the trial focuses on identifying drug treatments tailored, or personalized, to the specific genomic changes within the tumors of children with aggressive cancers. Also referred to as precision medicine, this type of research aims to customize drug treatment plans to the unique genetic makeup of an individual's tumor cell. Highly advanced computations provide explicitly detailed genomic information. In the trial, researchers study tumor biopsies using DNA and RNA sequencing performed at TGen. The data is then shared with Spectrum Health and analyzed using Dell computer power and complex algorithms constructed by the research team. An international group of physicians and researchers collaborate on the findings - through a customized online virtual meeting space - and design recommended treatment plans targeted for each patient's tumor. Ray Saab, MD, pediatric oncologist, American University of Beirut, Lebanon, is the physician investigator for the Lebanon arm of the NMTRC precision medicine trial.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Translational Genomics Research Institute, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at